Filters

COVID-19 and FINRA Arbitrations – FINRA Announcement on Postponements

04.23.2020
Robert I. Rabinowitz

Due to COVID-19, the Financial Industry Regulatory Authority said Monday that it has postponed all in-person arbitration and mediation proceedings scheduled through July 3. Parties that have an in-person hearing or mediation session scheduled through this date will be contacted by FINRA staff to reschedule or discuss remote scheduling options. […]

Areas of Focus: Business Litigation, Corporate

Nasdaq Adopts Emergency Temporary Relief Due to the Spread of COVID-19

04.23.2020
Michael A. GoldsteinSamantha A. Lesser

As a result of the market uncertainty unleashed by the COVID-19 crisis, the Nasdaq Stock Market (“Nasdaq”) has seen an increased number of issuers become non-compliant with its continued listing requirements for maintaining a minimum bid price and the market value of publicly-held shares (hereinafter “Price Requirements”). On April 17, […]

Areas of Focus: Business Litigation, Corporate

Recent SEC Actions in the Wake of COVID-19

04.17.2020
Michael A. GoldsteinSamantha A. Lesser

In light of the unprecedented disruptions associated with COVID-19, the U.S. Securities and Exchange Commission (the “SEC”) has recently released a number of public statements providing advice and regulatory relief to public companies due to the impact of COVID-19. NYSE Waiver of Shareholder Approval Requirements In an measure to provide […]

Areas of Focus: Corporate